Health and Human Services News and Research

RSS

Study finds neuromelanin-sensitive MRI as potential biomarker for psychosis

Researchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sensitive MRI is a potential biomarker for psychosis.

18 Feb 2019

New protocol could help physicians to rule out bacterial infections in infants

A new protocol could help emergency room physicians to rule out life-threatening bacterial infections among infants up to 2 months of age who have fevers, potentially eliminating the need for spinal taps, unnecessary antibiotic treatments or expensive hospital stays.

18 Feb 2019

Study finds genetic vulnerability to use of menthol cigarettes

A genetic variant found only in people of African descent significantly increases a smoker's preference for cigarettes containing menthol, a flavor additive.

15 Feb 2019

Large-scale clinical trial begins to study liver transplantation between people with HIV

The first large-scale clinical trial to study liver transplantation between people with HIV has begun at clinical centers across the United States. The HOPE in Action Multicenter Liver Study will determine the safety of this practice by evaluating liver recipients for potential transplant-related and HIV-related complications following surgery.

15 Feb 2019

FDA authorizes new interoperable insulin pump for children, adults with diabetes

The U.S. Food and Drug Administration today permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes.

15 Feb 2019

FDA warns doctor for illegally marketing unapproved implantable device

Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.

14 Feb 2019

NIH scientists zero in on genes associated with AMD

National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration, a leading cause of vision loss and blindness among people age 65 and older.

12 Feb 2019

NIH and partners host meeting to discuss the future of spinal cord injury research

The National Institutes of Health (NIH) and its partners will host a meeting of researchers, clinicians, patients and patient advocates to discuss spinal cord injury (SCI) research and to chart a course of future studies.

12 Feb 2019

FDA issues warning letters to companies for selling unapproved products that claim to treat Alzheimer’s

The U.S. Food and Drug Administration today posted 12 warning letters and 5 online advisory letters issued to foreign and domestic companies that are illegally selling more than 58 products, many that are sold as dietary supplements, which are unapproved new drugs and/or misbranded drugs that claim to prevent, treat or cure Alzheimer's disease and a number of other serious diseases and health conditions.

12 Feb 2019

Inexpensive nutritional supplement for women may help improve growth of fetus

For women in resource-poor settings, taking a certain daily nutritional supplement before conception or in early pregnancy may provide enough of a boost to improve growth of the fetus, according to a study funded by the National Institutes of Health.

11 Feb 2019

New clinical trial aims to examine safety and use of two HIV prevention tools

A clinical trial has begun to examine the safety and use of two HIV prevention tools--oral pre-exposure prophylaxis and a vaginal ring--in adolescent girls and young women in southern Africa.

8 Feb 2019

FDA takes initiative to adopt modern technologies for enhancing security of the drug supply chain

A key element of the U.S. Food and Drug Administration's mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality. This means working to ensure greater accountability in our nation's drug supply chain.

8 Feb 2019

Clinical study provides clear answer to debate on glucose management after stroke

Hyperglycemia, or increased glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal glucose levels.

8 Feb 2019

Nearly 35% of rural counties in the US experience significant population loss

Nearly 35 percent of rural counties in the United States are experiencing protracted and significant population loss, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

Noting that science has "brought a once-distant dream within reach," President Donald Trump on Tuesday night pledged to eliminate HIV transmission within 10 years.

6 Feb 2019

HEROES awarded two grants to support opioid intervention program in Houston

The Houston Emergency Response Opioid Engagement System was recently awarded two grants that will help fund the opioid intervention program through the end of 2020.

6 Feb 2019

Ideas to curb surprise medical bills percolate with rare bipartisan push

Surrounded by patients who told horror stories of being stuck with hefty bills, President Donald Trump recently waded into a widespread health care problem for which almost everyone — even those with insurance — is at risk: surprise medical billing.

5 Feb 2019

Psoriasis treatment associated with reduction in coronary artery disease

Researchers have found that treating psoriasis, a chronic inflammatory skin disease, with biologic drugs that target immune system activity can reduce the early plaque buildup that clogs arteries, restricts blood flow, and leads to heart attacks and stroke.

5 Feb 2019

MedStar experts collaborate with AMA to address patient safety, clinician burnout issues

Marking the 10th anniversary of the landmark federal act that encouraged hospitals, clinics, and physician offices to adopt electronic health record systems, MedStar Health experts in patient safety and health information technology are collaborating with the American Medical Association to push for changes to address the known risks to patient safety and clinician burnout that stem from poor EHR usability.

5 Feb 2019

Health and Human Services News and Research

Study finds neuromelanin-sensitive MRI as potential biomarker for psychosis

New protocol could help physicians to rule out bacterial infections in infants

Study finds genetic vulnerability to use of menthol cigarettes

Large-scale clinical trial begins to study liver transplantation between people with HIV

FDA authorizes new interoperable insulin pump for children, adults with diabetes

FDA warns doctor for illegally marketing unapproved implantable device

NIH scientists zero in on genes associated with AMD

NIH and partners host meeting to discuss the future of spinal cord injury research

FDA issues warning letters to companies for selling unapproved products that claim to treat Alzheimer’s

Inexpensive nutritional supplement for women may help improve growth of fetus

New clinical trial aims to examine safety and use of two HIV prevention tools

FDA takes initiative to adopt modern technologies for enhancing security of the drug supply chain

Clinical study provides clear answer to debate on glucose management after stroke

Nearly 35% of rural counties in the US experience significant population loss

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

HEROES awarded two grants to support opioid intervention program in Houston

Ideas to curb surprise medical bills percolate with rare bipartisan push

Psoriasis treatment associated with reduction in coronary artery disease

MedStar experts collaborate with AMA to address patient safety, clinician burnout issues

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News